Evidence map›Paper›PMID 36153019›Full record

ArticleBMJ open2022

Neonatal acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the community of a low-income country (NeoLIC): protocol for a household cohort study in Moramanga, Madagascar.

Aina Harimanana, Andriniaina Rakotondrasoa, Lalainasoa Odile Rivoarilala, Alexis Criscuolo, Lulla Opatowski, Elliot Fara Nandrasana Rakotomanana, Perlinot Herindrainy, Jean-Marc Collard, Tania Crucitti, Bich-Tram Huynh and 1 more

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aina HarimananaInstitut Pasteur de Madagascar, Antananarivo, Madagascar.
Andriniaina RakotondrasoaInstitut Pasteur de Bangui, Bangui, République Centrafricaine.
Lalainasoa Odile RivoarilalaInstitut Pasteur de Madagascar, Antananarivo, Madagascar.ORCID 0000-0002-4899-1996
Alexis CriscuoloInstitut Pasteur, Paris, Île-de-France, France.ORCID 0000-0002-8212-5215
Lulla OpatowskiInstitut Pasteur, Paris, Île-de-France, France.
Elliot Fara Nandrasana RakotomananaInstitut Pasteur de Madagascar, Antananarivo, Madagascar.
Perlinot HerindrainyInfectious Disease Detection and Surveillance, ICF International, Antananarivo, Madagascar.
Jean-Marc CollardInstitut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.ORCID 0000-0002-1490-3978
Tania CrucittiInstitut Pasteur de Madagascar, Antananarivo, Madagascar.ORCID 0000-0002-2235-6038
Bich-Tram HuynhInstitut Pasteur, Paris, Île-de-France, France bich-tram.huynh@pasteur.fr.ORCID 0000-0001-6340-9557
NeoLIC study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionData regarding the acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) in neonates at the community level are scarce in low-income and middle-income countries (LMICs), where the burden of neonatal sepsis is high.Our study aims at identifying and quantifying the role of the different routes of ESBL-PE transmission for neonates, which are still undefined in the community in LMICs. METHODS AND ANALYSIS: In a semirural community in Madagascar, 60 mothers and their neonates will be recruited at delivery, during which a maternal stool sample and meconium of the newborn will be collected. Home visits will be planned the day of the delivery and next at days 3, 7, 14, 21 and 28. Stool samples from the newborn, the mother and every other household member will be collected at each visit, as well as samples from the environment in contact with the newborn (food, surfaces and objects). Sociodemographic data and factors which might drive ESBL-PE acquisition will also be collected.We will analyse the isolated ESBL-PE using DNA sequencing methods to characterise clones, resistance genes and plasmids of ESBL-PE. To analyse these data globally, we will develop novel analytical approaches combining mathematical modelling and statistics. Finally, mathematical simulations will be performed to test different strategies of control of ESBL-PE transmission to neonates.In complement, we will conduct an anthropological investigation to understand local environments and practices that would contribute to neonatal ESBL-PE acquisition. In-depth interviews with members of 16 households will be conducted and 4 mother-newborn pairs will be followed by a participants' observations methodology. ETHICS AND DISSEMINATION: The study was approved by the ethical committee in Madagascar and by the institutional review board of Institut Pasteur, Paris, France.Findings will be reported to participating families, collaborators and local government; presented at national and international conferences and disseminated by peer-review publications.

Indexed as

beta-LactamasesEnterobacteriaceae InfectionsAnti-Bacterial AgentsCohort StudiesEnterobacteriaceaeHumansInfant, NewbornMadagascarAnti-Bacterial Agentsbeta-LactamasesBACTERIOLOGYCommunity child healthEpidemiologyNEONATOLOGY

Identifiers

PMID36153019
PMCPMC9511544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.